SCOPUS 정보 검색 플랫폼

Cancer

Volumn 72, Issue 12 S, 1993, Pages 3799-3802

Is disease flare a problem?

(1) Mahler, C a

a MIDDELHEIM HOSPITAL (Belgium)

Author keywords

flare; monotherapy; prostate cancer

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ACID PHOSPHATASE BLOOD LEVEL; ADVANCED CANCER; CANCER HORMONE THERAPY; CONFERENCE PAPER; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SYMPTOMATOLOGY; TESTOSTERONE BLOOD LEVEL;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; GONADORELIN; HUMAN; LUTEINIZING HORMONE; MALE; PROSTATIC NEOPLASMS; TESTOSTERONE; TREATMENT OUTCOME;

EID: 0027452109 PISSN: 0008543X EISSN: 10970142 Source Type: Journal
DOI: 10.1002/1097-0142(19931215)72:12+<3799::AID-CNCR2820721707>3.0.CO;2-9 Document Type: Article

Times cited : (43)

References (43)

1
- 0021039504
- Preliminary results on the clinical efficacy and safety of androgen inhibition by an LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma
- (1983) Prostate , vol.4 , Issue.6 , pp. 601-624
- Faure, N¹ Lemay, A² Laroche, B³ Robert, G⁴ Plante, R⁵ Jean, C⁶

2
- 0021247965
- 6‐LHRH‐analogue with metastatic prostatic cancer
- (1984) Lancet , vol.1 , pp. 971-972
- Kahan, A¹ Delrieu, F² Amor, B³ Chiche, R⁴ Steg, A⁵

3
- 0014154355
- Response of men with advanced prostatic carcinoma to exogenous administration of testosterone
- (1967) Cancer , vol.20 , pp. 1871-1878
- Prout, GR¹ Brewer, WR²

4
- 85005186867
- Palllative treatment of prostatic cancer with radioactive phosphorus
- (1976) Excerpta Med Int Congress Ser , vol.178 , pp. 22-25
- Denis, LJ¹ Prout, GR² Michielsen, JP³

5
- 85005064405
- Androgen priming and chemotherapy in advanced prostate cancer
- (1987) J Endocrinol Invest , vol.10 , pp. 32
- Manni, A¹ Santen, R² Boucher, A³ Lipton, A⁴ Harvey, H⁵ White, D⁶

6
- 0020960219
- Gonadotrophin releasing hormone analogues for the palliation of carcinoma of the prostate
- (1983) World J Urol , vol.1 , pp. 40-48
- Wenderoth, UK¹ Jacobi, GH²

7
- 0002113801
- April;, Las Vegas, Americal Urologicl Association
- (1983) Causes of prostatic tumor flare during treatment with LHRH agonist analogs [abstract]. Proceedings of the 78th annual meeting of the American Urological Association , pp. 100
- Trachtenberg, J¹

8
- 0021204716
- Treatments of patients with advanced cancer of the prostate using a slow release (depot) formulation of the LH‐RH agonist ICI 118630 (Zoladex)
- (1984) Journal of Endocrinology , vol.103 , pp. R1
- Walker, KJ¹ Turkes, AO² Turkes, A³ Zwinck, R⁴ Beacock, CJM⁵ Buck, AC⁶

9
- 0021323894
- Potential use of analogs of luteinizing hormone‐releasing hormones in the treatment of hormone‐sensitive neoplasms
- (1984) Cancer Treat Rep , vol.68 , pp. 281-289
- Schally, AV¹ Redding, TW² Comaru‐Schally, AM³

10
- 0022409045
- An LH‐RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections
- (1985) Eur J Surg Oncol , vol.11 , pp. 159-165
- Robinson, MRG¹ Denis, L² Mahler, C³ Walker, K⁴ Stitch, R⁵ Lunglmayr, G⁶

11
- 0022856883
- 6‐LH‐RH in prostatic carcinoma: comparison with other hormonal agents
- (1986) Prostate , vol.9 , pp. 327-342
- Mathé, G¹ Schally, AV² Comaru‐Schally, AM³

12
- 0024402997
- Short term antiandrogen therapy and very long acting depot gonadotrophin releasing hormone agonist for prostatic cancer
- Murphy GP, Khoury S, editors., New York, Alan R. Liss
- (1989) Therapeutic progress in urological cancer , pp. 61-68
- Waxman, JH¹

13
- 85005003912
- The Dutch South Eastern Urological Cooperative Group. Clinical research with the depot preparation Zoladex in prostate cancer. Abstract book, EORTC Symposium., Sept 14–15; Rotterdam.
- (1986)
- Debruyne, F¹ Witjes, FA²

14
- 84889119006
- Treatment with the gonadotrophin releasing hormone in advanced prostatic cancer
- (1983) BMJ , vol.286 , pp. 1305-1312
- Waxman, JH¹ Was, JAH² Hendry, WF³ Whitfield, HN⁴ Besser, GM⁵ Malpas, JS⁶

15
- 85004974556
- Endocrine and clinical evaluation of 107 patients with advanced prostatic carcinoma under long‐term pernasal Buserelin or intramuscular decapeptyl depot treatment
- Klijn J, editor., New York, Raven Press
- (1987) Hormonal manipulation of cancer: peptides, grow factors and new (anti) steroid agents , pp. 235-248
- Jacobi, GH¹ Wenderoth, UK² Ehrenthal, W³ Ulrich, K⁴

16
- 85005080686
- Long‐term results with a long‐acting formulation of D‐Trp‐6 LH‐RH in patients with prostate cancer: an Italian prostatic cancer project (PONCAP) study [abstract]. Proceedings of the First International Symposium on Advances in Urologic Oncology;, Jan 22–24; San Remo (Italy).
- (1987)
- Boccardo, F¹ Decensi, A² Guarneri, D³ Rubagotti, A⁴ Massa, T⁵ Martorana, G⁶

17
- 84915217952
- Leuprolide versus diethylstilbestrol for metastatic prostatic cancer
- Klijn J, editor., New York, Raven Press
- (1987) Hormonal manipulation of cancer: peptides, grow factors and new (anti) steroid agents , pp. 301-308
- Swanson, LJ¹ Garnick, MB²

18
- 0023074345
- Treatment of advanced prostatic cancer with LHRH‐analogues: prevention of “flare up” phenomenon
- Murphy GP, Khoury S, Küss R, Chatelain C, Denis L, editors., New York, Alan R. Liss
- (1987) Prostate cancer, part A: research, endocrine treatment, and histopathology , pp. 255-260
- Bouffioux, C¹ Denis, L² Mahler, C³ De Leval, J⁴

19
- 0023137576
- Zoladex (ICI 118.630): clinical trial of new luteinizing hormone‐releasing hormone analog in metastatic prostatic carcinoma
- (1987) Urology , vol.2 , pp. 185-190
- Murphy, GP¹ Greco, JM² Chin, JL³ Huben, RP⁴ Scott, M⁵ de Haen, HA⁶

20
- 0024352813
- Initiation of LHRH monotherapy for prostate cancer
- New York, Alan R. Liss
- (1989) Therapeutic progress in urological cancer , pp. 69-74
- Milsted, RAV¹

21
- 85005157782
- Long term results with LHRH analogue in patients with advanced prostatic cancer
- Murphy GP, Khoury S, Küss R, Chatelain C, Denis L, editors., New York, Alan R. Liss
- (1987) Prostate cancer, part A: research, endocrine treatment, and histopathology , pp. 221-227
- Denis, L¹ Mahler, C² Debruyne, FMJ³ Lunglmayr, G⁴ Newling, D⁵ Robinson, MRG⁶

22
- 84994995185
- LHRH agonist combination treatment
- Motta M, Sero M, editors., Apeldoorn, Medicom Europe BV
- (1987) Hormonal therapy of prostatic diseases: basic and clinical aspects , pp. 85-92
- Denis, L¹ Mahler, C²

23
- 0025139788
- Preliminary clinical evaluation of leuprorelin acetate depot injection in France, in the management of prostatic cancer
- (1990) J Int Med Res , vol.18 , pp. 69-73
- Navratil, H¹

24
- 0025059016
- Luteinizing hormone releasing hormone agonists: the US experience
- (1990) J Int Med Res , vol.18 , pp. 31-34
- Nabors, W¹ Crawford, ED²

25
- 0013157820
- Rationale for maximal androgen withdrawal in the therapy of prostate cancer
- (1988) Baillieres Clin Oncol , vol.3 , pp. 597-619
- Labrie, F¹ Belanger, A² Veilleux, R³ Lacoste, D⁴ Labrie, C⁵ Marchetti, B⁶

26
- 0024324367
- A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
- (1989) N Engl J Med , vol.321 , pp. 419-424
- Crawford, ED¹ Eisenberger, MA² McLeod, D³ Spaulding, JT⁴ Benson, R⁵ Dorr, FA⁶

27
- 0022498937
- Le traitement du cancer avancé de la prostate au moyen des analogues du LHRH: comment prèvenir la flambée initiale?
- (1986) Acta Urol Belg , vol.54 , pp. 304-308
- Bouffioux, C¹ Denis, L² Mahler, C³ De Leval, J⁴

28
- 84908812620
- Inhibition of LHRH analogues induced testosterone surge by blockade of androgen receptors [abstract]
- (1987) J Urol , vol.137 , pp. 4
- Aulitzky, W¹ Frick, J² Joes, H³ Hauser, W⁴

29
- 0021089571
- Combined treatment with ketoconazole and luteinizing hormone‐releasing hormone analogue: a novel approach to resistant progressive prostatic cancer
- (1983) BMJ , vol.287 , pp. 1766
- Allen, JM¹ Kerle, DJ² Ware, H³

30
- 0022251016
- DES lead‐in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostate
- (1985) Urology , vol.25 , Issue.4 , pp. 350-353
- Stein, BS¹ Smith, JA²

31
- 0024243923
- Simultaneous administration of a luteinizing hormone releasing hormone agonist and diethylstilbestrol in the initial treatment of prostatic cancer
- S127, 8
- (1988) American Journal of Clinical Oncology , vol.11
- Mahler, C¹ Denis, L²

32
- 0023693982
- Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare up in metastatic prostatic cancer?
- (1988) Urology , vol.332 , pp. 137
- Fernandez del Moral, P¹ Litjens, TTJ² Weil, EH³ Debruyne, FMJ⁴

33
- 0024352809
- Zoladex versus Zoladex plus flutamide in the treatment of advanced prostate cancer: first interim analysis of an international trial
- New York, Alan R. Liss
- (1989) Therapeutic progress in urological cancer , pp. 145-151
- Lunglmayer, G¹

34
- 0024340648
- Prevention of transient adverse effects of a gonadotrophin releasing hormone analog (Buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide)
- (1989) N Eng J Med , vol.321 , pp. 413-418
- Kuhn, JM¹ Billebaud, T² Navratil³ Moulonguet, A⁴ Fiet, S⁵ Grise, P⁶

35
- 0024221905
- Antiandrogens in combination with LHRH agonists in prostate cancer
- S132, 47
- (1988) Am J Clin Oncol , vol.11
- Raynaud, JP¹

36
- 0025154437
- Antiandrogenic substances in the management of prostatic cancer
- (1990) Recent results Cancer res. , vol.118 , pp. 163-173
- Schroder, F.H.¹

37
- 0026035942
- Pharmacology of antiandrogens and value of combining androgen suppression with antiandrogen therapy
- (1991) Urology , vol.37 , pp. 5-12
- Gaillard Moguilewsky, M¹

38
- 0026080598
- Castration plus nilutamide vs castration plus placebo in advanced prostate cancer: a review
- (1991) Urology , vol.37 , pp. 20-24
- Du Plessis, DJ¹

39
- 0021869415
- Combined treatment with buserelin and cyproterone acetate in metastatic prostatic carcinoma
- (1985) Lancet , vol.2 , pp. 493
- Klijn, JGM¹ de Voogt, HJ² Schroeder, FH³ de Jong, FH⁴

40
- 85004957253
- Advantages and disadvantages of pure antiandrogens and of antiandrogens of the cyproterone acetate‐type in the treatment of prostatic cancer
- Smith PH, Pavone‐Macaluso M, editors., New York, Alan R. Liss
- Management of advanced cancer of the prostate and bladder , vol.198 , pp. 63-75
- Habenicht, UF¹ Schroeder, H² El Etreby, F³ Neumann, F⁴

41
- 0025646640
- Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study
- (1990) Eur Urol , vol.18 , pp. 54-61
- Di Silverio, F¹ Serio, M² D'Eramo, G³ Sciarra, F⁴

42
- 0025611827
- Preliminary results of EORTC‐trial 30843
- (1990) J Steroid Biochem Mol Biol , vol.37 , Issue.6 , pp. 965-969
- de Voogt, HJ¹ Klijn, JG² Studer, U³ Schröder, F⁴ Sylvester, R⁵ De Pauw, MM⁶

43
- 0022973082
- Cyproterone acetate lead‐in prevents initial rise of serum testosterone induced by LHRH analogs in the treatment of metastatic carcinoma of the prostate
- (1986) Eur Urol , vol.12 , pp. 400-402
- Boccon‐Gibod, L¹ Laudat, MH² Dugue, MA³ Steg, A⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.